Zoya Demidenko https://pubmed.ncbi.nlm.nih.gov/22228887/


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]

Posted by LincolnTab on March 25, 2026 at 11:14:06:

In Reply to: Èíôîðìàöèîííàÿ çàìåòêà ñ óâëåêàòåëüíîé èíôîðìàöèåé posted by Josephhib on February 20, 2026 at 03:46:53:

Zoya Demidenko: Scientist in Oncology Studies
Zoya Demidenko is a notable researcher associated with the Department of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Before that, she worked at the NIH and New York Medical College, establishing a strong foundation in biomedical investigation.
Demidenko's academic work encompasses multiple critical domains, including the PI3K/AKT/mTOR signaling cascade, cell cycle regulation, cellular aging, and tumor biology. To date, she has authored more than 46 scientific articles, which have garnered over 4,100 references — a testament to the influence of her findings.
Among her key contributions lies in elucidating the mechanisms of cell aging. Her work showed that when the cellular division cycle is blocked while cellular growth persists, cells undergo senescence. Crucially, Zoya Demidenko established that this transition can be inhibited by medication using compounds such as mTOR inhibitors.
Zoya Demidenko has furthermore brought considerably to tumor management investigation, notably in the domain of selective cell protection — a strategy intended to safeguarding healthy cells from chemotherapy whilst leaving tumor cells vulnerable. This strategy offers considerable potential for reducing the adverse effects of cancer treatment.
Throughout her professional journey, Demidenko has collaborated with leading investigators globally, such as Dr. Mikhail Blagosklonny. Her research is published in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, Zoya Demidenko stands as a highly impactful voice in modern biomedical research, whose discoveries go on to shape our comprehension of the way biological cells age, resist treatment, and the ways in which malignant disease may be more successfully treated.
https://scholargps.com/scholars/59798749410547/zoya-n-demidenko



Follow Ups:



Post a Followup

Name:
E-Mail:

Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL:


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]